Cornacoff J B, Hebert L A, Smead W L, VanAman M E, Birmingham D J, Waxman F J
J Clin Invest. 1983 Feb;71(2):236-47. doi: 10.1172/jci110764.
Previous in vitro studies have shown that immune complexes (IC) that fix complement can bind to the C3b receptor on primate erythrocytes. The in vivo function of this erythrocyte receptor, however, is unknown. This study was undertaken to determine whether the binding of IC to erythrocytes in vivo might play a role in the removal of IC from the circulation. Baboons and rhesus monkeys were prepared with a catheter in the ascending aorta to infuse IC and in the abdominal aorta, renal, hepatic, and portal veins to monitor changes in binding and clearance of IC across kidney, liver, and spleen + gut, respectively. Autologous 51Cr-labeled erythrocytes were infused intravenously and allowed to equilibrate. Preformed IC (125I-labeled bovine serum albumin [BSA] rabbit anti-BSA) were then infused into the ascending aorta at a constant rate for 120 s. Blood samples were drawn at frequent intervals for 30 min from all catheters below the IC injection site. Each blood sample was then centrifuged on percoll to separate IC bound to erythrocytes from IC in plasma or bound to buffy coat cells. This resulted in an "erythrocyte fraction" beneath the percoll that contained the IC bound to erythrocytes, and a "plasma/buffy coat fraction" above the percoll that contained the IC in plasma and IC bound to buffy coat cells. Analysis of these data showed that the majority of the IC infused into the circulation rapidly became bound to erythrocytes. However, by 5 min after beginning the IC infusion, most of this IC load had been removed from the erythrocytes as they traversed the liver. In contrast, IC on erythrocytes did not deposit in kidney. The IC-bearing erythrocytes themselves were not trapped or detained by any organ. IC in the plasma/buffy coat fraction of blood were removed from the circulation but at a relatively low rate and almost entirely by the liver. These findings suggest that primate erythrocytes intercept large complement-fixing IC in the circulation causing the IC to adhere to the erythrocyte until th e IC-bearing erythrocyte traverses liver where the IC is deposited, and the erythrocyte is returned to the circulation. This primate erythrocyte-IC-clearing mechanism may be important in the protection against diseases mediated by deposition of circulating IC.
先前的体外研究表明,能够固定补体的免疫复合物(IC)可与灵长类动物红细胞上的C3b受体结合。然而,这种红细胞受体在体内的功能尚不清楚。本研究旨在确定IC在体内与红细胞的结合是否可能在从循环中清除IC的过程中发挥作用。给狒狒和恒河猴在升主动脉中置入导管以注入IC,并在腹主动脉、肾静脉、肝静脉和门静脉中置入导管,分别监测IC在肾脏、肝脏和脾脏+肠道中的结合和清除变化。将自体51Cr标记的红细胞静脉注入并使其达到平衡。然后将预先形成的IC(125I标记的牛血清白蛋白[BSA]兔抗BSA)以恒定速率注入升主动脉120秒。在IC注射部位下方的所有导管处每隔一段时间采集血样30分钟。然后将每个血样在 Percoll上离心,以将与红细胞结合的IC与血浆中的IC或与血沉棕黄层细胞结合的IC分离。这导致在Percoll下方形成一个“红细胞部分”,其中包含与红细胞结合的IC,在Percoll上方形成一个“血浆/血沉棕黄层部分”,其中包含血浆中的IC和与血沉棕黄层细胞结合的IC。对这些数据的分析表明,注入循环中的大多数IC迅速与红细胞结合。然而,在开始注入IC后5分钟,当这些IC负载的红细胞穿过肝脏时,大部分IC已从红细胞上清除。相比之下,红细胞上的IC不会沉积在肾脏中。携带IC的红细胞本身不会被任何器官捕获或滞留。血液中血浆/血沉棕黄层部分的IC从循环中被清除,但速率相对较低,且几乎完全由肝脏清除。这些发现表明,灵长类动物红细胞在循环中拦截大量固定补体的IC,导致IC粘附在红细胞上,直到携带IC的红细胞穿过IC沉积的肝脏,然后红细胞返回循环。这种灵长类动物红细胞-IC清除机制可能在预防由循环IC沉积介导的疾病中起重要作用。